Robert A Bermel

机构：Cleveland Clinic · ORCID：0000-0003-2334-6883

发表论文 22 篇 · 总被引 798 次 · h-index 10

代表论文

• How patients with multiple sclerosis acquire disability (2022 · Brain · 被引 555)
• AI-driven reclassification of multiple sclerosis progression (2025 · Nature Medicine · 被引 34)
• TH17 cells promote CNS inflammation by sensing danger signals via Mincle (2022 · Nature Communications · 被引 34)
• Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials (2024 · Therapeutic Advances in Neurological Disorders · 被引 25)
• Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial (2021 · Multiple Sclerosis Journal · 被引 25)
• Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions (2022 · Multiple Sclerosis Journal · 被引 21)